washingtonpost.com  > Business > Policy > Trade

Quick Quotes

TV Ads for Sex Supplement Challenged

Reuters
Thursday, September 23, 2004; Page A30

Pro-Erex. Big Daddy. Suregasm. There is little doubt what these supplements are promising, but the evidence that they actually can enhance a man's sexual performance falls short, a consumer group said Wednesday.

The Center for Science in the Public Interest, best known for taking the fun out of Chinese takeout and ice cream by revealing how unhealthful such treats are, is now taking on the nonprescription sex supplement industry.

_____Interactive Primer_____
Understanding Regulatory Policy
_____Related SEC Articles_____
SEC Wants Fixes, Not Fines (The Washington Post, Sep 29, 2004)
MCI Not Liable for Legal Costs From SEC Investigation (The Washington Post, Sep 22, 2004)
Housing Starts Up in August (The Washington Post, Sep 22, 2004)
More SEC News
_____About the SEC_____
Mission
History
Key Issues
Who's in Charge?
__  Regulatory News By Agency __

The CSPI filed a complaint yesterday with the Federal Trade Commission saying that one company, Cincinnati-based Berkeley Premium Nutraceuticals, had crossed the line in television ads touting its supplement Enzyte.

"We urge the Federal Trade Commission to immediately enjoin the national television advertisements of Berkeley Premium Nutraceuticals, for the herbal supplement Enzyte," the complaint, faxed to the FTC, reads.

"The FTC requires that advertising claims for dietary supplements, including those based on testimonials of users, 'be backed by sound, scientific evidence.' Berkeley, however, has conceded that it has no scientific studies of Enzyte substantiating any of Berkeley's claims."

A spokesman for Berkeley Premium Nutraceuticals was not immediately available.

Under U.S. law, supplements are not regulated by the Food and Drug Administration in the way prescription drugs are.


© 2004 The Washington Post Company